1h Free Analyst Time
The biobanking market is forecasted to grow by USD 1.66 billion during 2023-2028, accelerating at a CAGR of 9.04% during the forecast period. The report on the biobanking market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing demand for personalized medicine, increase in efficiency through automation, and reduction in research costs.
The biobanking market is segmented as below:
By Type
- Physical
- Virtual
By Product
- Equipment
- Consumables
By Geography
- Europe
- North America
- Asia
- Rest of World (ROW)
The report on the biobanking market covers the following areas:
- Biobanking market sizing
- Biobanking market forecast
- Biobanking market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global biobanking market: AMS Biotechnology Europe Ltd., ASKION GmbH, Azenta Inc., Bay Biosciences LLC, BioIVT LLC, Boca Biolistics LLC, CTIBiotech, Cureline Inc., Danaher Corp., Firalis SA, GENETICIST Inc., Greiner Bio One International GmbH, Hamilton Co., OraSure Technologies Inc., PHC Holdings Corp., Promega Corp., ProteoGenex Inc., Shanghai Genext Medical Technology Co. Ltd., Thermo Fisher Scientific Inc., and US Biolab Corp. Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is emergence of stem cells storage in biobanks."
According to the report, one of the major drivers for this market is the growing demand for personalized medicine.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AMS Biotechnology Europe Ltd.
- ASKION GmbH
- Azenta Inc.
- Bay Biosciences LLC
- BioIVT LLC
- Boca Biolistics LLC
- CTIBiotech
- Cureline Inc.
- Danaher Corp.
- Firalis SA
- GENETICIST Inc.
- Greiner Bio One International GmbH
- Hamilton Co.
- OraSure Technologies Inc.
- PHC Holdings Corp.
- Promega Corp.
- ProteoGenex Inc.
- Shanghai Genext Medical Technology Co. Ltd.
- Thermo Fisher Scientific Inc.
- US Biolab Corp. Inc.
